Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Change in Inventory (2022 - 2025)

TriSalus Life Sciences' Change in Inventory history spans 4 years, with the latest figure at -$199000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 514.58% year-over-year to -$199000.0; the TTM value through Dec 2025 reached -$971000.0, down 164.6%, while the annual FY2025 figure was -$971000.0, 164.6% down from the prior year.
  • Change in Inventory reached -$199000.0 in Q4 2025 per TLSIW's latest filing, up from -$531000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $915000.0 in Q4 2023 to a low of -$531000.0 in Q3 2025.
  • Average Change in Inventory over 4 years is $137692.3, with a median of $114000.0 recorded in 2025.
  • Peak YoY movement for Change in Inventory: skyrocketed 419.63% in 2024, then crashed 514.58% in 2025.
  • A 4-year view of Change in Inventory shows it stood at $185000.0 in 2022, then skyrocketed by 394.59% to $915000.0 in 2023, then tumbled by 94.75% to $48000.0 in 2024, then plummeted by 514.58% to -$199000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Change in Inventory are -$199000.0 (Q4 2025), -$531000.0 (Q3 2025), and -$355000.0 (Q2 2025).